(BBIO) BridgeBio Pharma - Performance 66.4% in 12m
BBIO performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
17.96%
#19 in Peer-Group
Rel. Strength
89.35%
#820 in Stock-Universe
Total Return 12m
66.41%
#19 in Peer-Group
Total Return 5y
35.05%
#23 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 45.12 USD |
| 52 Week Low | 22.35 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 83.06 |
| Buy/Sell Signal +-5 | 0.48 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: BBIO (66.4%) vs XBI (-10.3%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-0.38% | 70.8% | 82.8% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.6% | -8.36% | 148% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.02% | -2.91% | 36% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.49% | 30.5% | -2.72% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
1.71% | -10.1% | -2.8% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
10.6% | 38.9% | -7.13% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.18% | 51.2% | -15.7% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
2.97% | 30.4% | 16.6% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: BBIO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BBIO
| Total Return (including Dividends) | BBIO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 11.45% | -0.81% | 3.81% |
| 3 Months | 41.83% | 14.52% | 23.42% |
| 12 Months | 66.41% | -10.32% | 13.17% |
| 5 Years | 35.05% | -27.72% | 112.04% |
| Trend Score (consistency of price movement) | BBIO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 84.8% | -6.5% | 81% |
| 3 Months | 72.9% | 79.4% | 97.3% |
| 12 Months | 82.2% | -86.4% | 45.1% |
| 5 Years | -25.1% | -52.3% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th86.50 | 12.36% | 7.36% |
| 3 Month | %th73.00 | 23.85% | 14.92% |
| 12 Month | %th91.00 | 85.57% | 47.04% |
| 5 Years | %th89.50 | 86.85% | -36.31% |
FAQs
Does BridgeBio Pharma (BBIO) outperform the market?
Yes,
over the last 12 months BBIO made 66.41%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.32%.
Over the last 3 months BBIO made 41.83%, while XBI made 14.52%.
Performance Comparison BBIO vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
BBIO vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.3% | 7.6% | 44.7% | 53% |
| US NASDAQ 100 | QQQ | 0.7% | 7.3% | 43.4% | 55% |
| German DAX 40 | DAX | 0.2% | 11.9% | 32.9% | 37% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.3% | 8.8% | 42.7% | 46% |
| Hongkong Hang Seng | HSI | 0.9% | 8.9% | 26.4% | 28% |
| India NIFTY 50 | INDA | 1.3% | 11.2% | 45.2% | 68% |
| Brasil Bovespa | EWZ | 1.6% | 6% | 25.1% | 59% |
BBIO vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.2% | 7.7% | 40.8% | 42% |
| Consumer Discretionary | XLY | 0.3% | 9.1% | 52.1% | 50% |
| Consumer Staples | XLP | -0.7% | 10.1% | 43.2% | 57% |
| Energy | XLE | -0.9% | 7.5% | 51.2% | 67% |
| Financial | XLF | 0.2% | 7.8% | 41% | 37% |
| Health Care | XLV | 1.1% | 10.8% | 53.8% | 72% |
| Industrial | XLI | -0.2% | 8.3% | 37.5% | 42% |
| Materials | XLB | -2.3% | 8.5% | 41.6% | 62% |
| Real Estate | XLRE | 0.6% | 11.5% | 45.4% | 55% |
| Technology | XLK | 0.1% | 4.9% | 41.5% | 57% |
| Utilities | XLU | 0.3% | 9.1% | 41.4% | 43% |
| Aerospace & Defense | XAR | 1.3% | 6.9% | 25.2% | 17% |
| Biotech | XBI | -0% | 12.3% | 60.8% | 77% |
| Homebuilder | XHB | -1.9% | 6.1% | 52.3% | 64% |
| Retail | XRT | -3% | 9.7% | 49.6% | 56% |
BBIO vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -3.9% | 5.30% | 52.9% | 71% |
| Natural Gas | UNG | 1.9% | 20.2% | 56.3% | 71% |
| Gold | GLD | -0.1% | 11.2% | 25.1% | 26% |
| Silver | SLV | -1.2% | 11.3% | 28.5% | 48% |
| Copper | CPER | 2.3% | 9.9% | 31.9% | 57% |
BBIO vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 2.8% | 10.3% | 48.4% | 70% |
| iShares High Yield Corp. Bond | HYG | 1% | 10% | 46.2% | 57% |